Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

9.530 -1.740 (-15.44%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
Can Biotech Stocks Continue Rallying In This Bear Market?
Via Talk Markets
What 7 Analyst Ratings Have To Say About Evolent Health
Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings: 
Via Benzinga
Privia Health Stock Receives IBD Stock Rating Upgrade
On Monday, Privia Health stock saw an improvement in its IBD SmartSelect Composite Rating, upgrading to 96 from 94. 
Via Investor's Business Daily
Chicago Faith Leaders Plan Coordinated Sermons to Destigmatize Mental Health in Underserved Communities
From Evolent Health
Via Business Wire
Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)
Via Investor Brand Network
Expert Ratings for Evolent Health
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter: 
Via Benzinga
What 6 Analyst Ratings Have To Say About Evolent Health
Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings: 
Via Benzinga
Evolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal
Via Benzinga
Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)
Via Investor Brand Network
Whither Small Caps After Fed’s Tough Talk?
For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and... 
Via Talk Markets
Veeva Systems Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
Veeva Systems stock reached a key technical milestone, with its Relative Strength Rating, rising to 81 on Tuesday, up from 66 the day before. 
Via Investor's Business Daily
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation?
The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring... 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is... 
Via Benzinga
4 Analysts Have This to Say About Evolent Health
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
The Nasdaq and small caps rose while the S&P 500 is hitting resistance. 
Via Investor's Business Daily
Evolent Health Is In Buy Zone Ahead Of Earnings Announcement
Medical cost management firm Evolent Health reports late Tuesday. 
Via Investor's Business Daily
Evolent Health's Earnings: A Preview
Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Evolent Health... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
Amazon's Acquisition Of One Medical Rattles Health Care Stocks
Amazon health care expansion plans, including its $3.9 billion acquisition of One Medical for about $3.9 billion, shook health care stocks. 
Via Investor's Business Daily
Small Cap Biotechs Regain Momentum
Smaller cap biotech stocks soared off from recent lows looking like a redux of early 2021 when prices were double that of current values. 
Via Talk Markets
Simulations Plus Stock Scores Composite Rating Move Up To 96
The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating. 
Via Investor's Business Daily
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
Privia Health Stock Among The Few That've Risen This Month
Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume. 
Via Investor's Business Daily
Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know
Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022
Upgrades 
Via Benzinga
Tough Slogging Ahead for Investors, Diversification is Important
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows. 
Via Talk Markets
Evolent Health 'Notification Award' Removes $82M Overhang, Notes Piper Sandler
In an SEC filing, Cook County named Evolent Health Inc (NYSE: EVH) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025.... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.